LYEONS Neurotech
LYEONS is a neurotechnology company developing innovative stimulation-based solutions to support brain health, such as anxiety, stress, trauma, and sleep disturbances. Our focus is on harnessing sensory and neuromodulation technologies to recalibrate the autonomic nervous system, with the aim of improving quality of life and enabling earlier intervention in conditions that impact brain and nervous system function.
Our approach combines hardware innovation with evidence-based methods, creating user-centred solutions that mimic parasympathetic activation and help restore balance in the body’s stress response. We are also building a community platform to bring together individuals, clinicians, and researchers to share insights, support, and resources.
LYEONS was founded by Lucy Jung, a design engineer and entrepreneur with a track record in medical device innovation. Previously, Lucy co-founded Charco Neurotech, where she led the development of a sensory neuromodulation device for Parkinson’s disease, raising over £13 million in funding and successfully introducing the device into the NHS and international markets. Drawing from both professional expertise and personal experiences with neurological challenges, LYEONS is passionate about advancing accessible technologies that make a real impact on people’s lives.
Founded in 2024, LYEONS builds on extensive experience in patient-centred neurotechnology innovation. Our mission is to combine hardware development, sensory modulation, and community-driven support to deliver accessible solutions that restore balance in the nervous system and support long-term brain health.
- 2024 – Company founded with a prototype showing promising early user testing results.
- 2025 – Selected for the Imperial College Enterprise Lab IVM programme to strengthen commercial strategy and build expert networks.
- 2025 – Joined the Cambridge Judge Business School Accelerator and the Babraham Research Campus Accelerate@Babraham programme, gaining expert guidance and translational support.
- 2025 – Awarded the Cambridge NeuroWorks Fellowship to extend neurotechnology studies and clinical validation.
The LYEONS team brings together expertise in:
- Design Engineering & Product Innovation – with a track record of developing and commercialising medical devices.
- Biomedical Science & Clinical Research – guiding user testing, clinical background research, and regulatory pathways.
- Electrical & Electronic Engineering – supporting hardware prototyping, system operations, and product optimisation.
- Business Development & Operations – scaling medical technologies from early-stage innovation to NHS and international markets.
Together, the team combines deep technical expertise with proven experience in bringing neurotechnology to patients, clinicians, and healthcare systems.
